241 related articles for article (PubMed ID: 3876160)
1. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
Barton RW
Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
[TBL] [Abstract][Full Text] [Related]
2. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
3. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
Checkik BE; Perets A; SenGupta S; Fernandes B
J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
[TBL] [Abstract][Full Text] [Related]
4. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
Cowan MJ; Shannon KM; Wara DW; Ammann AJ
Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
[TBL] [Abstract][Full Text] [Related]
5. The distribution of adenosine deaminase among lymphocyte populations in the rat.
Barton R; Martiniuk F; Hirschhorn R; Goldschneider I
J Immunol; 1979 Jan; 122(1):216-20. PubMed ID: 310828
[TBL] [Abstract][Full Text] [Related]
6. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
[TBL] [Abstract][Full Text] [Related]
7. p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency.
Benveniste P; Cohen A
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8373-7. PubMed ID: 7667298
[TBL] [Abstract][Full Text] [Related]
8. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
9. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
Ratech H; Hirschhorn R; Thorbecke GJ
Am J Pathol; 1985 Apr; 119(1):65-72. PubMed ID: 3872599
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
11. Relevance of adenosine deaminase to organ transplantation.
Lum CT; Sutherland DE; Hsiao N; Najarian JS
Ann N Y Acad Sci; 1985; 451():113-22. PubMed ID: 3907451
[TBL] [Abstract][Full Text] [Related]
12. Studies of the relationship between adenosine deaminase and immune function.
Burridge PW; Paetkau V; Henderson JF
J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
[TBL] [Abstract][Full Text] [Related]
13. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
14. Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency.
Cowan MJ; Smith W; Ammann AJ
Clin Immunol Immunopathol; 1989 Oct; 53(1):59-67. PubMed ID: 2569954
[TBL] [Abstract][Full Text] [Related]
15. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
Prentice HG; Smyth JF; Ganeshaguru K; Wonke B; Bradstock KF; Janossy G; Goldstone AH; Hoffbrand AV
Lancet; 1980 Jul; 2(8187):170-2. PubMed ID: 6105339
[TBL] [Abstract][Full Text] [Related]
16. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
Thuillier L; Garreau F; Cartier PH
Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
[TBL] [Abstract][Full Text] [Related]
17. Further differentiation of murine double-positive thymocytes is inhibited in adenosine deaminase-deficient murine fetal thymic organ culture.
Van De Wiele CJ; Joachims ML; Fesler AM; Vaughn JG; Blackburn MR; McGee ST; Thompson LF
J Immunol; 2006 May; 176(10):5925-33. PubMed ID: 16670300
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
19. Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).
Resta R; Hooker SW; Laurent AB; Jamshedur Rahman SM; Franklin M; Knudsen TB; Nadon NL; Thompson LF
J Clin Invest; 1997 Feb; 99(4):676-83. PubMed ID: 9045870
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 2 liberation and absorption capacities of rat T lymphocytes in conditions of severe adenylic nucleotide pool depletion due to adenosine deaminase deficiency.
Thuillier L; Arenzana-Seisdedos F; Pérignon JL; Munier A; Hamet M; Cartier PH
Immunopharmacology; 1985 Oct; 10(2):89-97. PubMed ID: 3877709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
